US–EU biometric talks advance
The U.S. and EU are in formal negotiations on a biometric data‑sharing agreement that could grant DHS access to EU biometric records—potentially changing admissibility and identity-verification dynamics. The move would heighten cross-jurisdictional demands for consistent identity documentation. (biometricupdate.com)
The EU Council formally authorised the Commission to open negotiations on 16 December 2025, and the first round of talks took place in January 2026. The Commission’s draft negotiating directives, published in July 2025, envisage an EU‑level framework that would be followed by bilateral implementing agreements between individual member states and the United States to specify databases and data categories. Public and leaked texts name core EU systems under discussion as Eurodac, the Schengen Information System (SIS), the Visa Information System (VIS), the Entry/Exit System (EES), ETIAS and ECRIS‑TCN, which contain asylum fingerprints, visa records and criminal‑history identifiers. Brussels has tied the negotiating push to U.S. requirements for continued Visa Waiver Program participation, and a parliamentary question cites a U.S. deadline of 31 December 2026 for member states to conclude bilateral arrangements. The European Data Protection Supervisor warned the proposal would be the EU’s “first agreement…entailing large‑scale sharing of personal data” with a third country and demanded narrow material scope, transparency, accountability mechanisms and specific limits on onward transfers. Reporting by Euractiv and civil‑society coalitions found draft language that permits automated queries and does not fully exclude algorithmic assessment of travellers, prompting repeated calls for a binding data‑protection impact assessment and mandatory human‑in‑the‑loop review. Next procedural steps require formal approval of a framework at EU and U.S. levels, after which member states are expected to negotiate implementing accords that will define technical standards, retention periods and individual remedies.
